
A Chinese medical laboratory Tuesday launched a joint program with Harvard University to study Tibetan herbal medicines, in an effort to see how they can help fight cancers. Researchers from China's Tibetan Medicine External Preparations Engineering Lab (Gansu), together with professors of Harvard's School of Public Health, will use new pharmaceutical technology to explore the mechanism behind Tibetan medicines' efficacy, especially in treating cancers. Harvard professor David Christiani said a number of traditional Tibetan herbal medicines can alleviate cancer symptoms and even prolong some patients' survival time. "Clinically, we know these herbs help, but it is not quite clear why and how they work scientifically," said Chrisitiani, who will work on the program with three of his Harvard colleagues. Tibetan medicines include more than 2,000 kinds of herbs that grow in Tibet, Gansu, Qinghai, Sichuan and Yunnan. Growing and collecting the herbs are one of the most important ways for Tibetans in these regions to make a living. Zhu Xiaoxin, a senior researcher with the China Academy of Chinese Medical Sciences, said the study on Tibetan medicines with advanced technologies could eventually help benefit patients. Lei Jufang, chairman of Gansu Cheezheng Tibetan Medicine Co., Ltd., said the study is expected to help improve the quality of her drugs and also benefit herb farmers.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor